PageOverview.com
 

Websites, domains, hosts that links to ssi.is

Our database shows, that the website ssi.is is linked by a total of 5 websites.

 
Number of websites/domains displayed: 5
Results found: 5
 

Websites discovered:

Smart Sight Innovations IT Solutions | SSI is Mumbai based website & mobile application development company
http://pageoverview.com/website-report/smartsight.in
  • Expected expiration: October 24th in 2019
  • Creation date: October 24th in 2013
  • Renew date: May 21st in 2015
  • Google Analytics: 100050737-1
  • AddThis User: ra-53a7c896407ba56e
Snohomish Sports Institute – (425)263-1201
http://pageoverview.com/website-report/snohomishsportsinstitute.com
Snohomish Sports Institute (SSI) is Snohomish County’s premier indoor sports facility for the elite athlete.
  • Expected expiration: January 23rd in 2019
  • Creation date: January 23rd in 2013
  • Renew date: January 22nd in 2018
  • Google Analytics: 50600476-1
  • Google Plus Account: 101401407026998207109
Verkalýðs- og sjómannafélag Sandgerðis
http://pageoverview.com/website-report/vsfs.is
Verkalýðs- og sjómannafélag Sandgerðis
  • Creation date: November 17th in 2008
  • Expected expiration: November 17th in 2018
IBD Clinical Trial | New Colitis Crohn's Treatment / Medication option | Qu Crohn's Trial
http://pageoverview.com/website-report/qucrohnstrial.com
QBECO SSI is a new investigational treatment for ulcerative colitis and Crohn's disease designed to restore the body’s innate immune system and correct the dysfunctional immune response related to inflammatory bowel disease. QBECO SSI is being studied in clinical trials for IBD.
  • Expected expiration: May 30th in 2018
  • Creation date: May 30th in 2012
  • Renew date: May 14th in 2017
IBD Clinical Trial | New Colitis Crohn's Treatment / Medication option | Qu Crohn's Trial
http://pageoverview.com/website-report/quibd.com
QBECO SSI is a new investigational treatment for ulcerative colitis and Crohn's disease designed to restore the body’s innate immune system and correct the dysfunctional immune response related to inflammatory bowel disease. QBECO SSI is being studied in clinical trials for IBD.
  • Expected expiration: July 7th in 2019
  • Creation date: July 7th in 2015
  • Renew date: September 7th in 2017
0.0399 // 2024-05-21 17:22:36
All Rights reserved 2018 © PageOverview.com